Key Takeaways

  • Plasma eMTBR-tau was far higher in former football players with high-stage CTE at autopsy (median 0.019 vs 0.001 pg/mL) in a 21-donor JAMA case series
  • The marker tracked total tau burden across 11 brain regions, but low-stage CTE was indistinguishable from no CTE
  • The study reports no accuracy figures and the assay is a research tool — there is no approved blood test for CTE

CTE can still only be confirmed after death. This is a step toward changing that

Chronic traumatic encephalopathy — the tau disease linked to repeated head impacts — can today only be diagnosed at autopsy. A study published in JAMA on November 19, 2026 tested whether a blood marker could see it coming.

Researchers at Boston University studied 21 former football players who had given blood during life and later donated their brains. At autopsy, 18 had CTE — 16 of them high-stage — and 3 did not. A plasma marker called eMTBR-tau, a fragment of the tau protein that forms CTE's tangles, was dramatically higher in the CTE group: a median of 0.019 pg/mL versus 0.001 in players without CTE. The marker also tracked the total tau burden across 11 brain regions. The highest levels of all were in donors who had CTE plus Alzheimer's-related changes (0.082 pg/mL).

The caveats are substantial. Low-stage CTE was indistinguishable from no CTE — the marker only separated advanced disease. Nearly half the samples fell below the assay's reliable measurement range. All 21 donors were men from one specialized centre's football cohorts, and the study reports no sensitivity or specificity figures — it cannot yet say how accurate a test would be. The authors' own conclusion is measured: the marker "may represent a feasible biomarker candidate" for high-stage CTE, and larger validation studies are needed.

Health note: There is no approved blood test for CTE, and this research assay is not available to the public. Anyone worried about symptoms after head impacts — memory, mood, impulse control — should see a doctor; treatable conditions can look similar.

The Twikup Take

The honest headline is narrower than the exciting one: a blood signal for advanced CTE, in 21 men, with early disease invisible to it. But the direction matters. Every prior step toward diagnosing CTE in life has stalled at the same wall — no measurable signal in blood. This study found one. What it has not found yet is a test.

Image: Illustrative image.

Sources